Control of infections associated with obliterative arterial disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D001157:Arterial Occlusive Diseases / Q000150:complications*; D004692:Endarteritis / Q000150:complications*; D007239:Infections / Q000628:therapy*; D013919:Thromboangiitis Obliterans; D014652:Vascular Diseases
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular
ANTIBIOTICS/therapeutic use; ENDARTERITIS OBLITERANS/complications; INFECTION/therapy